← Leaderboards
Gary D Luker
University Of Michigan At Ann Arbor
$13,466,981
Attributed
$25,730,193
Total exposure
17
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2006–25$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$25,730,193 · 17
By mechanism
R01$14,396,212 · 7
U01$3,553,884 · 1
U24$3,116,461 · 1
R33$1,437,586 · 1
R21$1,330,766 · 3
S10$939,608 · 1
Top collaborators
- Brian D. Ross10 shared
- Moshe Talpaz10 shared
- Shuichi Takayama9 shared
- Hossein Tavana7 shared
- Pradipta Ghosh6 shared
- Thomas L. Chenevert5 shared
- Katsuo Kurabayashi5 shared
- Joerg Lahann5 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Craig J Galban$12,293,457
- Brian D. Ross$27,286,369
- Lan Coffman$1,681,245
- Moshe Talpaz$1,805,257
- Katsuo Kurabayashi$1,800,647
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsCellsImageSignal TransductionBreast Cancer CellMalignant Breast NeoplasmResponseNeoplasm MetastasisCancer CellIn VivoMouse ModelMolecularEnvironmentTechnologySiteTumorTissuesCancer TherapyInnovationEngineeringHeterogeneityDrug DevelopmentBaseDesign
Grant awards (63)
Integrated Imaging Tools for Intercellular Chemokine Signalling$218,788
R61 · FY2025 · CA · contact PI
Cell and Tissue Imaging (CTI)$125,956
P30 · FY2025 · CA · contact PI
Sensing and modulating the chemokine environment with synthetic cells$234,000
R21 · FY2024 · AI
Integrated Imaging Tools for Intercellular Chemokine Signalling$207,850
R61 · FY2024 · CA · contact PI
University of Michigan Quantitative Co-Clinical Imaging Research Resource$615,843
U24 · FY2023 · CA
Imaging Disease Heterogeneity and Response to Therapy in Myelofibrosis$608,237
R01 · FY2023 · CA
Integrated Imaging Tools for Intercellular Chemokine Signalling$218,790
R61 · FY2023 · CA · contact PI
Sensing and modulating the chemokine environment with synthetic cells$195,000
R21 · FY2023 · AI
Integrators of Metastatic Potential$179,694
R01 · FY2023 · CA
University of Michigan Quantitative Co-Clinical Imaging Research Resource$615,843
U24 · FY2022 · CA
Imaging Disease Heterogeneity and Response to Therapy in Myelofibrosis$608,237
R01 · FY2022 · CA
Integrators of Metastatic Potential$498,678
R01 · FY2022 · CA
University of Michigan Quantitative Co-Clinical Imaging Research Resource$627,953
U24 · FY2021 · CA
Environmental Regulation of Cancer Stem Cell Plasticity in Metastasis$625,201
U01 · FY2021 · CA · contact PI
Imaging Disease Heterogeneity and Response to Therapy in Myelofibrosis$620,650
R01 · FY2021 · CA
Integrators of Metastatic Potential$508,573
R01 · FY2021 · CA
A High Throughput Human Tumor Modeling Technology for Cancer Drug Discovery$365,045
R33 · FY2021 · CA
A High Throughput Human Tumor Modeling Technology for Cancer Drug Discovery$166,399
R33 · FY2021 · CA
Integrators of Metastatic Potential$98,453
R01 · FY2021 · CA
A High Throughput Human Tumor Modeling Technology for Cancer Drug Discovery$59,188
R33 · FY2021 · CA
Environmental Regulation of Cancer Stem Cell Plasticity in Metastasis$880,606
U01 · FY2020 · CA · contact PI
University of Michigan Quantitative Co-Clinical Imaging Research Resource$628,411
U24 · FY2020 · CA
Imaging Disease Heterogeneity and Response to Therapy in Myelofibrosis$620,650
R01 · FY2020 · CA
Integrators of Metastatic Potential$508,004
R01 · FY2020 · CA
A High Throughput Human Tumor Modeling Technology for Cancer Drug Discovery$370,110
R33 · FY2020 · CA
University of Michigan Quantitative Co-Clinical Imaging Research Resource$628,411
U24 · FY2019 · CA
Imaging Disease Heterogeneity and Response to Therapy in Myelofibrosis$620,650
R01 · FY2019 · CA
Environmental Regulation of Cancer Stem Cell Plasticity in Metastasis$600,262
U01 · FY2019 · CA · contact PI
Integrators of Metastatic Potential$522,054
R01 · FY2019 · CA
A High Throughput Human Tumor Modeling Technology for Cancer Drug Discovery$476,844
R33 · FY2019 · CA
Systems Bioengineering of Cancer Cell Migration$437,470
R01 · FY2019 · CA · contact PI
Environmental Regulation of Cancer Stem Cell Plasticity in Metastasis$718,923
U01 · FY2018 · CA · contact PI
Systems Bioengineering of Cancer Cell Migration$449,826
R01 · FY2018 · CA · contact PI
Environmental Regulation of Cancer Stem Cell Plasticity in Metastasis$728,892
U01 · FY2017 · CA · contact PI
Systems Bioengineering of Cancer Cell Migration$447,397
R01 · FY2017 · CA · contact PI
Systems Bioengineering of Cancer Cell Migration$434,360
R01 · FY2016 · CA · contact PI
Systems Bioengineering of Cancer Cell Migration$431,856
R01 · FY2015 · CA · contact PI
Modeling Therapy of Disseminated Cancer Cells in Bone Marrow (PQ 17)$327,803
R01 · FY2015 · CA · contact PI
Targeted Multi-Spectral Dual Axes Confocal Imaging of In Vivo Molecular Expressio$454,422
R01 · FY2014 · CA
Modeling Therapy of Disseminated Cancer Cells in Bone Marrow (PQ 17)$317,970
R01 · FY2014 · CA · contact PI
A Novel High Throughput Tumor Spheroid Microtechnology$245,707
R21 · FY2014 · CA
Targeted Multi-Spectral Dual Axes Confocal Imaging of In Vivo Molecular Expressio$450,074
R01 · FY2013 · CA
Modeling Therapy of Disseminated Cancer Cells in Bone Marrow (PQ 17)$340,859
R01 · FY2013 · CA · contact PI
Microfluidic Models of Metastatic Cancer$285,537
R01 · FY2013 · CA · contact PI
Molecular Imaging of Chemokine Receptor Signaling$284,011
R01 · FY2013 · CA · contact PI
A Novel High Throughput Tumor Spheroid Microtechnology$257,466
R21 · FY2013 · CA
Targeted Multi-Spectral Dual Axes Confocal Imaging of In Vivo Molecular Expressio$487,740
R01 · FY2012 · CA
Modeling Therapy of Disseminated Cancer Cells in Bone Marrow (PQ 17)$378,626
R01 · FY2012 · CA · contact PI
Microfluidic Models of Metastatic Cancer$304,106
R01 · FY2012 · CA · contact PI
Molecular Imaging of Chemokine Receptor Signaling$302,397
R01 · FY2012 · CA · contact PI
Targeted Multi-Spectral Dual Axes Confocal Imaging of In Vivo Molecular Expressio$495,399
R01 · FY2011 · CA
Molecular Imaging of Chemokine Receptor Signaling$302,646
R01 · FY2011 · CA · contact PI
Microfluidic Models of Metastatic Cancer$302,183
R01 · FY2011 · CA · contact PI
Olympus FV1000-MPE Confocal & Multi-Photon Imaging System$939,608
S10 · FY2010 · RR · contact PI
Targeted Multi-Spectral Dual Axes Confocal Imaging of In Vivo Molecular Expressio$518,564
R01 · FY2010 · CA
Molecular Imaging of Chemokine Receptor Signaling$312,256
R01 · FY2010 · CA · contact PI
Microfluidic Models of Metastatic Cancer$311,960
R01 · FY2010 · CA · contact PI
Molecular Imaging of Chemokine Receptor Signaling$312,499
R01 · FY2009 · CA · contact PI
Microfluidic Models of Metastatic Cancer$312,371
R01 · FY2009 · CA · contact PI
Imaging Vaccina Viral-Host Pathogenesis$213,653
R21 · FY2007 · AI · contact PI
Imaging Vaccina Viral-Host Pathogenesis$184,940
R21 · FY2006 · AI · contact PI
MDR1 P-GLYCOPROTEIN AND CHOLESTEROL TRAFFICKING$105,992
K08 · FY2001 · HL
MDR1 P-GLYCOPROTEIN AND CHOLESTEROL TRAFFICKING$78,300
K08 · FY2000 · HL